W.P. Steward
Impact in
- Oncology top 5%
- Vascular Tumors and Angiosarcomas
- Peptidase Inhibition and Analysis
-
- Sarcoma Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 16
- Cancer Treatment and Pharmacology 4
- Colorectal Cancer Treatments and Studies 3
- Lung Cancer Research Studies 2
-
- Lung Cancer Treatments and Mutations 8
- Sarcoma Diagnosis and Treatment 3
- Co-authors
- Jaap Verweij (6 shared papers)R. Somers (2 shared papers)Armando Santoro (2 shared papers)Henning T. Mouridsen (3 shared papers)J. Buesa (2 shared papers)Paolo G. Casali (1 shared paper)Elaine M. Rankin (1 shared paper)D. Spooner (1 shared paper)
- Journals
- European Journal of Cancer (4 papers)Journal of Clinical Oncology (3 papers)British Journal of Cancer (2 papers)Lung Cancer (2 papers)Annals of Oncology (2 papers)
- Partner nations
- United KingdomItalyBelgium
In The Last Decade
W.P. Steward
30 papers receiving 1.0k citations
W.P. Steward's Hit Papers
Peers
Comparison fields: 5 of 77
- Oncology 419
- Pulmonary and Respiratory Medicine 451
- Hematology 110
- Cancer Research 141
- Pathology and Forensic Medicine 129
Countries citing papers authored by W.P. Steward
This map shows the geographic impact of W.P. Steward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.P. Steward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.P. Steward more than expected).
Fields of papers citing papers by W.P. Steward
This network shows the impact of papers produced by W.P. Steward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.P. Steward. The network helps show where W.P. Steward may publish in the future.
Co-authors
The 25 scholars most cited alongside W.P. Steward, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Hit paper breakdown → | 1995 | 438 |
| 2 | Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer. | 2001 | 112 |
| 3 | 2004 | 108 | |
| 4 | 1996 | 75 | |
| 5 | Phase I/II study of gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results. | 1996 | 51 |
| 6 | 2003 | 46 | |
| 7 | 1984 | 29 | |
| 8 | 2003 | 28 | |
| 9 | 1998 | 23 | |
| 10 | 1996 | 23 | |
| 11 | 2007 | 21 | |
| 12 | Ifosfamide plus doxorubicin in previously untreated patients with advanced soft-tissue sarcoma. | 1993 | 21 |
| 13 | Treatment of relapsed non-Hodgkin's lymphoma with a combination of hydroxyurea, ifosfamide, and etoposide. | 1985 | 16 |
| 14 | 1995 | 13 | |
| 15 | 2006 | 10 | |
| 16 | 1991 | 9 | |
| 17 | Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma Group. | 1992 | 8 |
| 18 | 2003 | 8 | |
| 19 | Phase I study of recombinant DNA granulocyte macrophage colony stimulating factor. | 1988 | 7 |
| 20 | Clinical application of hematopoietic growth factors. | 1990 | 4 |
About W.P. Steward
W.P. Steward is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Pathology and Forensic Medicine, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (4 papers), Sarcoma Diagnosis and Treatment (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), Lung Cancer Research Studies (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (419 citations), Pulmonary and Respiratory Medicine (451 citations), Hematology (110 citations), Cancer Research (141 citations) and Pathology and Forensic Medicine (129 citations). W.P. Steward has collaborated with scholars based in United Kingdom, Italy and Belgium. Frequent co-authors include Jaap Verweij, R. Somers, Armando Santoro, Henning T. Mouridsen, J. Buesa, Paolo G. Casali, Elaine M. Rankin, D. Spooner, T Türsz and A. Gescher. Their work appears in journals such as European Journal of Cancer, Journal of Clinical Oncology, British Journal of Cancer, Lung Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.